患有ERBB2插入突变的晚期盆癌患者:一个病例报告
Peipei Shang1, Cheng Lou1, Lei Yin1
1Department of Oncology, Shanghai Eastern Hepatobiliary Surgery Hospital, Anting Town, Jiading District, Shanghai, China.
The Journal of international medical research
|November 2, 2023
概括
患有ERBB2突变的晚期盆癌症初步对trastuzumab产生反应. 然而,药物耐药性发展,突出了治疗这种罕见癌症的挑战.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 病理学 病理学 病理学
背景情况:
- 脏盆腔癌的预后不好,晚期的治疗选择有限.
- 激活ERBB2中的突变与某些晚期癌症有关.
- 这个病例重点是一个60多岁的男性患者,患有晚期盆癌和肝转移.
更多相关视频
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
9.0K
07:50Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
Published on: May 25, 2018
8.3K
